Xtant Medical Holdings XTNT
NYSE XTNT
$0.33 -0.01 (-2.94%)
At close: Aug 20, 2026 · 4:00 PM EDT

Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)

Xtant Medical Holdings (XTNT) posted quarterly Asset Writedowns and Impairment of $78000.0 for Q3 2025, down 74.59% year-over-year from $307000.0 in Q3 2024, and up 252.94% quarter-over-quarter from -$51000.0 in Q2 2025.

Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends

Xtant Medical Holdings (XTNT) has reported Asset Writedowns and Impairment for 9 consecutive years, with $78000.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Asset Writedowns and Impairment fell 74.59% year-over-year to $78000.0; the TTM figure through Sep 2025 stood at $358000.0 (down 45.26% YoY), while the FY2024 annual figure was $485000.0, up 35.85% from the prior year.
  • Asset Writedowns and Impairment climbed to $78000.0 in Q3 2025 per XTNT's latest filing, from -$51000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $864000.0 in Q4 2021 and bottomed at -$210000.0 in Q4 2024.
  • Historically, Asset Writedowns and Impairment has averaged $204736.8 across 5 years, with a median of $129000.0 in 2024.
  • Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment jumped 7754.55% — and 2024, when it tumbled 412.2%.
  • Xtant Medical Holdings' Asset Writedowns and Impairment stood at $864000.0 in 2021, then tumbled by 71.76% to $244000.0 in 2022, then sank by 116.8% to -$41000.0 in 2023, then sank by 412.2% to -$210000.0 in 2024, then soared by 137.14% to $78000.0 in 2025.
  • Business Quant data shows XTNT's Asset Writedowns and Impairment at $78000.0 in Q3 2025, -$51000.0 in Q2 2025, and $541000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Xtant Medical Holdings 46.53 Mn 28.93 Mn 17.75 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 78,000.00
Sep 30, 2025 78,000.00
Jun 30, 2025 -51,000.00
Jun 30, 2025 -51,000.00
Mar 31, 2025 541,000.00
Mar 31, 2025 541,000.00
Dec 31, 2024 -210,000.00
Dec 31, 2024 -210,000.00
Sep 30, 2024 307,000.00
Sep 30, 2024 307,000.00
Jun 30, 2024 129,000.00
Jun 30, 2024 129,000.00
Mar 31, 2024 259,000.00
Mar 31, 2024 259,000.00
Dec 31, 2023 -41,000.00
Dec 31, 2023 -41,000.00
Sep 30, 2023 155,000.00
Sep 30, 2023 155,000.00
Jun 30, 2023 153,000.00
Jun 30, 2023 153,000.00